Skip to main content
The Precision Peptide Company Inc. (CSE:BPC)
Canada flag Canada · Delayed Price · Currency is CAD
0.470
-0.010 (-2.08%)
At close: Apr 27, 2026

CSE:BPC Revenue

The Precision Peptide Company had revenue of 42.99K CAD in the quarter ending January 31, 2026. This brings the company's revenue in the last twelve months to 92.71K, up 2,116.42% year-over-year. In the fiscal year ending October 31, 2025, The Precision Peptide Company had annual revenue of 49.72K with 307.47% growth.

Revenue (ttm)
92.71K
Revenue Growth
+2,116.42%
P/S Ratio
221.89
Revenue / Employee
n/a
Employees
2
Market Cap
20.57M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Oct 31, 202549.72K37.52K307.47%
Oct 31, 202412.20K-273.39K-95.73%
Oct 31, 2023285.59K-295.40K-50.84%
Oct 31, 2022580.99K463.57K394.79%
Oct 31, 2021117.42K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

The Precision Peptide Company News

More News